EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Biologics in the treatment of severe asthma in children and adults—updates 2024-2025

Courtney L Gaberino, Jason Moraczewski, Daniel J Jackson, Leonard B Bacharier

Journal of Allergy and Clinical Immunology · 2026

DOI: 10.1016/j.jaci.2026.01.002 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Allergy and Clinical Immunology, 2026. Verfasst von Courtney L Gaberino und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wis. Electronic address: gaberino@wisc.edu. Hauptthemen laut MEDLINE: Asthma, Biological Products, Anti-Asthmatic Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of targeted mAbs has transformed the treatment of moderate-to-severe asthma. The main clinical trial outcomes have focused on exacerbation reduction and lung function improvement. In the past few years, there have been many high-quality studies examining pathophysiologic effects of the biologic therapies, giving insight into their downstream impacts. Clinical remission is a growing area of interest, and many studies highlight the utility as well as the limitations of commonly available biomarkers to predict treatment response. This review synthesizes the results of recent clinical trials and related topics focusing on relevant updates to the literature since 2024, highlighting new indications for use, predictors of response, safety data, real-world comparative effectiveness, remission, and mechanistic advances.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaBiological ProductsAnti-Asthmatic AgentsHumansChild

Stichwörter der Autor:innen

Severe asthmabiologics

Substanzen

Biological ProductsAnti-Asthmatic Agents

Autor:innen und Institutionen

  • Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wis. Electronic address: gaberino@wisc.edu.
  • Monroe Carell, Jr, Children's Hospital at Vanderbilt University Medical Center, Nashville, Tenn.
  • Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wis.

Zitieren

APA

Gaberino, C. L., Moraczewski, J., Jackson, D. J., & Bacharier, L. B. (2026). Biologics in the treatment of severe asthma in children and adults—updates 2024-2025. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2026.01.002

Vancouver

Gaberino CL, Moraczewski J, Jackson DJ, Bacharier LB. Biologics in the treatment of severe asthma in children and adults—updates 2024-2025. Journal of Allergy and Clinical Immunology. 2026. doi:10.1016/j.jaci.2026.01.002

BibTeX
@article{Gaberino2026,
  author = {Gaberino, Courtney L and Moraczewski, Jason and Jackson, Daniel J and Bacharier, Leonard B},
  title = {Biologics in the treatment of severe asthma in children and adults—updates 2024-2025},
  journal = {Journal of Allergy and Clinical Immunology},
  year = {2026},
  doi = {10.1016/j.jaci.2026.01.002}
}
Kostenlos starten →